Abstract Introduction: In Cuba, lung cancer represents the first cause of mortality for both
sexes. Non-small cell lung cancer (NSCLC) is the most prevalent histology. Overall, 75-85 …

Interventions: Continued treatment with gemcitabine alone following the 6 cycles of cisplatin–
gemcitabine chemotherapy, prolonging the interval of chemotherapy when he could not …

Background: Lung cancer (LC) is currently the leading cause of cancer death globally. LC
accounts for a high mortality and incidence rate of cancer in both men and women …

Abstract Treatment of elderly or poor performance status (PS) patients with advanced non-
small-cell lung cancer (NSCLC) is a debated topic. To evaluate the efficacy of a modified …

Areas covered: The authors analyzed the state of the art of pemetrexed through a review of
the literature. Clinical trials and meta-analyses involving pemetrexed in NSCLC were …

Standard chemotherapy regimes (platinum-based combinations) for advanced non-small-
cell lung cancer have reached their therapeutic limits. In the last few years standard …

Purpose: Racotumomab is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-
associated ganglioside. This clinical trial was conducted to provide a preliminary estimate of …

Σήμερα ο τρόπος που αντιμετωπίζουμε το καρκίνο του πνεύμονα έχει αλλάξει προς μία πιο
ορθολογιστική χρήση των θεραπευτικών μας επιλογών. Από το μοντέλο του 20ου αιώνα που …

Well-conducted meta-analyses are a powerful and useful instrument to produce synthesis of
all the evidence available on a specific clinical issue. In recent years, like in other fields of …

Chemotherapy in the treatment of advanced nonsmall-cell lung cancer (NSCLC) has
reached a plateau of effectiveness. Unfortunately, most patients have advanced disease at …